Hinge Bio Raises $30 Million Series A’ Financing to Develop Next-Generation Therapies via its Proprietary GEM-DIMER Platform
Funding will support the development of Company’s lead product candidate for autoimmune disease as well as novel constructs to treat other indications with significant unmet need.BURLINGAME, Calif., ...
Hosted on MSN14h
Are Bar Carts Out? Here's How to Give Yours New Life (with Gen Z-Approved Tips)
The internet has an opinion on everything, and lately, the online powers have declared the bar cart "out." So what do you do ...